Literature DB >> 20350706

A novel method to quantify histochemical changes throughout the mediolateral axis of the substantia gelatinosa after spared nerve injury: characterization with TRPV1 and substance P.

Gregory Corder1, Andrew Siegel, Allison B Intondi, Xing Zhang, James E Zadina, Bradley K Taylor.   

Abstract

UNLABELLED: Nerve injury dramatically increases or decreases protein expression in the spinal cord dorsal horn. Whether the spatial distribution of these changes is restricted to the central innervation territories of injured nerves or could spread to adjacent territories in the dorsal horn is not understood. To address this question, we developed a simple computer software-assisted method to precisely distinguish and efficiently quantify immunohistochemical staining patterns across the mediolateral axis of the dorsal horn 2 weeks after transection of either the tibial and common peroneal nerves (thus sparing the sural branch, spared nerve injury, [SNI]), the tibial nerve, or the common peroneal and sural nerves. Using thiamine monophosphatase (TMP) histochemistry, we determined that central terminals of the tibial, common peroneal, sural, and posterior cutaneous nerves occupy the medial 35%, medial-central 20%, central-lateral 20%, and lateral 25% of the substantia gelatinosa, respectively. We then used these calculations to show that SNI reduced the expression of SP and TRPV1 immunoreactivity within the tibial and peroneal innervation territories in the L4 dorsal horn, without changing expression in the uninjured, sural sector. We conclude that SNI-induced loss of SP and TRPV1 in central terminals of dorsal horn is restricted to injured fibers. Our new method enables direct comparison of injured and uninjured terminals in the dorsal horn so as to better understand their relative contributions to mechanisms of chronic pain. PERSPECTIVE: A simple computer software-assisted algorithm was developed to precisely distinguish and efficiently quantify immunohistochemical staining patterns across the mediolateral axis of the dorsal horn after distal sciatic-branch transection. This method will facilitate a better understanding of the relative contribution of injured and uninjured terminals to mechanisms of chronic pain. Copyright 2010 American Pain Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350706      PMCID: PMC2872064          DOI: 10.1016/j.jpain.2009.09.008

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  36 in total

1.  Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn.

Authors:  J G Valtschanoff; A Rustioni; A Guo; S J Hwang
Journal:  J Comp Neurol       Date:  2001-07-23       Impact factor: 3.215

2.  Laminar distribution and somatotopic organization of primary afferent fibers from hindlimb nerves in the dorsal horn. A study by transganglionic transport of horseradish peroxidase in the rat.

Authors:  C Molander; G Grant
Journal:  Neuroscience       Date:  1986-09       Impact factor: 3.590

3.  Fiber composition of the rat sciatic nerve.

Authors:  H Schmalbruch
Journal:  Anat Rec       Date:  1986-05

4.  The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord.

Authors:  J E Swett; C J Woolf
Journal:  J Comp Neurol       Date:  1985-01-01       Impact factor: 3.215

5.  Thiamine monophosphatase: a genuine marker for transganglionic regulation of primary sensory neurons.

Authors:  E Knyihár-Csillik; A Bezzegh; S Böti; B Csillik
Journal:  J Histochem Cytochem       Date:  1986-03       Impact factor: 2.479

6.  Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve.

Authors:  Maria Schäfers; Christian Geis; Camilla I Svensson; Z David Luo; Claudia Sommer
Journal:  Eur J Neurosci       Date:  2003-02       Impact factor: 3.386

7.  Somatotopic organization of cutaneous afferent terminals and dorsal horn neuronal receptive fields in the superficial and deep laminae of the rat lumbar spinal cord.

Authors:  C J Woolf; M Fitzgerald
Journal:  J Comp Neurol       Date:  1986-09-22       Impact factor: 3.215

8.  Increase of preprotachykinin mRNA and substance P immunoreactivity in spared dorsal root ganglion neurons following partial sciatic nerve injury.

Authors:  W Ma; M A Bisby
Journal:  Eur J Neurosci       Date:  1998-07       Impact factor: 3.386

9.  Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis.

Authors:  Shannon D Shields; William A Eckert; Allan I Basbaum
Journal:  J Pain       Date:  2003-10       Impact factor: 5.820

10.  The vanilloid receptor-1 (TRPV1) is expressed in some rat dorsal horn NK1 cells.

Authors:  Stéphane Doly; Jacqueline Fischer; Marie Conrath
Journal:  Brain Res       Date:  2004-04-09       Impact factor: 3.252

View more
  13 in total

1.  Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.

Authors:  N K Katz; J M Ryals; D E Wright
Journal:  Neuroscience       Date:  2014-11-08       Impact factor: 3.590

2.  Analysis of spontaneous activity of superficial dorsal horn neurons in vitro: neuropathy-induced changes.

Authors:  Carolina Roza; Irene Mazo; Iván Rivera-Arconada; Elsa Cisneros; Ismel Alayón; José A López-García
Journal:  Pflugers Arch       Date:  2016-10-10       Impact factor: 3.657

3.  Axotomy of tributaries of the pelvic and pudendal nerves induces changes in the neurochemistry of mouse dorsal root ganglion neurons and the spinal cord.

Authors:  Carly J McCarthy; Eugenia Tomasella; Mariana Malet; Kim B Seroogy; Tomas Hökfelt; Marcelo J Villar; G F Gebhart; Pablo R Brumovsky
Journal:  Brain Struct Funct       Date:  2015-03-07       Impact factor: 3.270

4.  Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.

Authors:  Ryan B Griggs; Renee R Donahue; Braxton G Adkins; Katie L Anderson; Olivier Thibault; Bradley K Taylor
Journal:  J Pain       Date:  2015-12-12       Impact factor: 5.820

5.  Topography and time course of changes in spinal neuropeptide Y immunoreactivity after spared nerve injury.

Authors:  A B Intondi; J E Zadina; X Zhang; B K Taylor
Journal:  Neuroscience       Date:  2009-10-30       Impact factor: 3.590

6.  Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms.

Authors:  Ryan B Griggs; Renee R Donahue; Jenny Morgenweck; Peter M Grace; Amanda Sutton; Linda R Watkins; Bradley K Taylor
Journal:  Pain       Date:  2015-03       Impact factor: 7.926

7.  Methylglyoxal Requires AC1 and TRPA1 to Produce Pain and Spinal Neuron Activation.

Authors:  Ryan B Griggs; Don E Laird; Renee R Donahue; Weisi Fu; Bradley K Taylor
Journal:  Front Neurosci       Date:  2017-12-06       Impact factor: 4.677

8.  Piezo2 mechanosensitive ion channel is located to sensory neurons and nonneuronal cells in rat peripheral sensory pathway: implications in pain.

Authors:  Seung Min Shin; Francie Moehring; Brandon Itson-Zoske; Fan Fan; Cheryl L Stucky; Quinn H Hogan; Hongwei Yu
Journal:  Pain       Date:  2021-11-01       Impact factor: 6.961

9.  Disruption of Spinal Noradrenergic Activation Delays Recovery of Acute Incision-Induced Hypersensitivity and Increases Spinal Glial Activation in the Rat.

Authors:  Vipin Arora; Carlos Eduardo Morado-Urbina; Carol A Aschenbrenner; Ken-Ichiro Hayashida; FuZhou Wang; Thomas J Martin; James C Eisenach; Christopher M Peters
Journal:  J Pain       Date:  2015-11-03       Impact factor: 5.383

10.  CD4+ αβ T cell infiltration into the leptomeninges of lumbar dorsal roots contributes to the transition from acute to chronic mechanical allodynia after adult rat tibial nerve injuries.

Authors:  Bin Du; You-Quan Ding; Xia Xiao; Hong-Yi Ren; Bing-Yin Su; Jian-Guo Qi
Journal:  J Neuroinflammation       Date:  2018-03-15       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.